Jacob S. Van Naarden
Chief Business Officer. In his previous roles,
Oncology and Molecular Radiation Sciences
Medpace
Norway
Biography
Jacob S. Van Naarden serves as Chief Business Officer. In his previous roles, Mr. Van Naarden served in various biotechnology investing, operating, and advisory capacities.
Research Interest
Previously, Mr. Van Naarden served as a public equity biotechnology analyst at HealthCor Management, a multi-billion dollar healthcare-dedicated investment firm based in NYC. Prior to HealthCor, Mr. Van Naarden was an Associate at Aisling Capital, a multi-strategy healthcare investment firm based in NY. Mr. Van Naarden started his career in the Healthcare Group of the Investment Banking Division at Goldman Sachs.
